A 65-year-old patient with lung cancer and confirmed metastatic adenocarcinoma is experiencing increased respiratory distress and fatigue. He has elevated liver enzymes and anemia. Which nursing intervention should be prioritized to address the patient's current respiratory issues?

C) Position the patient in a high Fowler's position to ease breathing.

A) Administer a bronchodilator to improve airway patency.

B) Increase the flow rate of supplemental oxygen to maintain oxygen saturation above 92%.

C) Position the patient in a high Fowler's position to ease breathing.

D) Schedule frequent rest periods to conserve energy and reduce fatigue.

A 65-year-old patient with metastatic lung cancer and liver involvement is experiencing increased dyspnea and fatigue. Which nursing intervention should be prioritized to address the patient's respiratory status?

C) Position the patient in a semi-Fowler's position to enhance lung expansion.

A) Encourage the patient to engage in light physical activity to improve lung capacity.

B) Increase the supplemental oxygen flow rate to maintain oxygen saturation above 95%.

C) Position the patient in a semi-Fowler's position to enhance lung expansion.

D) Administer a bronchodilator to alleviate respiratory distress.

A patient with a history of lung cancer shows signs of respiratory distress with an oxygen saturation of 88% on 4L of oxygen via nasal cannula, an elevated respiratory rate, and accessory muscle use. The healthcare team is considering initiating non-invasive ventilation. Which of the following assessments should the nurse prioritize to determine the immediate need for this intervention?

A) Monitor the patient's level of consciousness and ability to protect their airway.

B) Evaluate the patient's nutritional intake and weight changes.

C) Review the patient's recent liver function test results.

D) Assess the patient's skin integrity and risk for pressure ulcers.

A patient with a history of liver involvement and recent respiratory distress presents with decreased oxygen saturation, elevated respiratory rate, and bilateral lung sounds changes. Given these findings, which nursing intervention should be prioritized to address the patient's immediate respiratory needs?

B) Initiate non-invasive positive pressure ventilation (NIPPV) to support breathing.

A) Increase the supplemental oxygen flow rate to 6 liters per minute via nasal cannula.

B) Initiate non-invasive positive pressure ventilation (NIPPV) to support breathing.

C) Administer a prescribed dose of diuretics to reduce potential pulmonary edema.

D) Position the patient in a high Fowler's position to facilitate lung expansion.

A patient with respiratory distress is being managed with a high-flow nasal cannula at 60% FiO2, and diuretics have been initiated to address possible fluid overload. The patient's respiratory rate remains elevated at 28 breaths per minute, and there is moderate use of accessory muscles. Which nursing intervention is most appropriate to prioritize in this situation?

D) Reassess fluid balance and adjust diuretic therapy based on urine output and renal function.

A) Increase the FiO2 on the high-flow nasal cannula to 70%.

B) Administer a bronchodilator to relieve respiratory distress.

C) Encourage the patient to use incentive spirometry to improve lung expansion.

D) Reassess fluid balance and adjust diuretic therapy based on urine output and renal function.

A patient with worsening respiratory distress and positive blood cultures for Gram-negative rods is being evaluated for changes in respiratory support. Which of the following interventions should the nurse anticipate as the most immediate priority to address the patient's current condition?

B) Preparing the patient for possible intubation and mechanical ventilation

A) Initiating high-flow nasal cannula oxygen therapy

B) Preparing the patient for possible intubation and mechanical ventilation

C) Administering bronchodilators to alleviate respiratory distress

D) Increasing the dose of diuretics to reduce pulmonary edema

A patient with worsening respiratory distress despite high-flow nasal cannula (HFNC) therapy shows signs of bacterial infection and is on an adjusted antibiotic regimen. What is the nurse's priority action when the patient's respiratory rate increases to 32 breaths per minute and the patient reports increased fatigue with difficulty in conversation?

D) Contact the healthcare provider to discuss the need for non-invasive ventilation.

A) Increase the oxygen flow rate on the HFNC to improve oxygenation.

B) Prepare for potential intubation by gathering necessary equipment.

C) Encourage the patient to perform deep breathing exercises to enhance lung expansion.

D) Contact the healthcare provider to discuss the need for non-invasive ventilation.

A patient with worsening respiratory acidosis and signs of hemodynamic instability is being managed with BiPAP and fluid resuscitation. Which nursing intervention is the highest priority to address the patient's current condition?

C) Administer norepinephrine to stabilize blood pressure.

A) Increase the BiPAP settings to improve ventilation.

B) Initiate continuous monitoring of vital signs and urine output.

C) Administer norepinephrine to stabilize blood pressure.

D) Prepare for potential intubation and mechanical ventilation.

A patient with worsening respiratory acidosis and signs of sepsis-induced hypotension is being managed with BiPAP and fluid resuscitation. Considering the current clinical scenario, which priority nursing intervention should be implemented to address the patient's hemodynamic instability while minimizing the risk of worsening respiratory status?

C) Initiate norepinephrine infusion to maintain adequate mean arterial pressure.

A) Increase the IPAP setting on the BiPAP to enhance ventilation.

B) Administer a rapid bolus of IV fluids to quickly improve blood pressure.

C) Initiate norepinephrine infusion to maintain adequate mean arterial pressure.

D) Encourage the patient to perform incentive spirometry to improve lung expansion.

Akciğer CA - Nursing Case Study

Pathophysiology

• Primary mechanism: Uncontrolled cell growth in the lung epithelium leads to tumor formation, often due to genetic mutations such as those in the EGFR or KRAS genes. This disrupts normal cell cycle regulation, allowing cells to proliferate uncontrollably.

• Secondary mechanism: Angiogenesis, the formation of new blood vessels, is stimulated by the tumor to supply necessary nutrients and oxygen. This process is driven by factors like VEGF, enabling further tumor growth and potential metastasis.

• Key complication: Tumor invasion into surrounding tissues and potential metastasis to distant organs, such as the brain or liver, can occur due to the breakdown of basement membranes and lymphatic spread, leading to significant morbidity and mortality.

Patient Profile

Demographics:

65-year-old male, retired construction worker

History:

• Key past medical history: Chronic Obstructive Pulmonary Disease (COPD), hypertension

• Current medications: Inhaled bronchodilators, lisinopril, aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent cough and shortness of breath

• Key symptoms: Weight loss, fatigue, hemoptysis, chest pain

• Vital signs: Blood pressure 150/90 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 37.8°C, oxygen saturation 88% on room air

Section 1

As the healthcare team continues to monitor the 65-year-old patient with a diagnosis of lung cancer, new diagnostic results reveal some concerning developments. A recent CT scan of the chest shows an increase in the size of the primary tumor in the left lung, with evidence of invasion into the pleura and potential involvement of the mediastinum. Additionally, there are suspicious nodules noted in the liver, suggesting possible metastatic spread. A biopsy confirms the presence of metastatic adenocarcinoma. Laboratory tests show elevated liver enzymes, with ALT and AST levels at 75 U/L and 82 U/L, respectively, indicating potential liver dysfunction. The patient's hemoglobin is noted to be 10.8 g/dL, suggestive of anemia, possibly due to chronic disease or nutritional deficiencies related to weight loss and decreased appetite.

In response to these findings, the patient's oxygen saturation has been more challenging to maintain, even with supplemental oxygen therapy. His respiratory rate has increased to 28 breaths per minute, and he appears more fatigued and dyspneic after minimal exertion. The care team initiates a palliative care consultation to better manage symptoms and improve quality of life. Chemotherapy and targeted therapy options are being discussed, considering the genetic mutation profile, to address both the primary tumor and the metastatic disease.

These developments require careful clinical reasoning and coordination of care. The nursing team must prioritize monitoring for respiratory distress, potential complications from liver involvement, and the patient's response to any new treatments. Education on symptom management and potential side effects of therapy will be vital as the patient's journey progresses, ensuring that both the patient and family are supported throughout this challenging time.

Section 2

As the healthcare team continues to manage the patient's condition, they observe a change in his status that prompts immediate attention. The patient's oxygen saturation has further decreased, now consistently hovering around 88% on 4 liters of supplemental oxygen via nasal cannula. His respiratory rate remains elevated at 30 breaths per minute, and he exhibits increased use of accessory muscles when breathing, indicating significant respiratory distress. On auscultation, diminished breath sounds are noted in the left lower lung field, accompanied by new crackles in the right lung base, suggesting possible fluid accumulation or atelectasis secondary to tumor progression.

In response to these changes, the nursing team conducts a thorough assessment to identify potential new complications. The patient's heart rate has increased to 110 bpm, and blood pressure is slightly elevated at 145/90 mmHg, which may reflect increased sympathetic nervous system activity due to hypoxia or anxiety. The team also notes a slight increase in the patient's temperature to 37.8°C, raising concerns about potential infection or inflammation. Given the recent findings of liver involvement, the team draws a repeat set of liver function tests, revealing further elevation in ALT and AST to 85 U/L and 90 U/L, respectively, alongside a slight rise in bilirubin levels to 2.1 mg/dL. This indicates worsening liver function, likely exacerbating the patient's fatigue and overall malaise.

The healthcare team convenes to discuss the implications of these findings. They consider adjusting the patient's oxygen therapy and possibly initiating non-invasive ventilation support to improve oxygenation and ease the work of breathing. The potential need for diuretics or corticosteroids is also discussed to address pulmonary symptoms and alleviate inflammation. Additionally, the team plans for closer monitoring of the patient's nutritional status and anemia, as these factors are critical to his overall resilience and ability to tolerate further oncologic treatments. The palliative care team reinforces the importance of maintaining open communication with the patient and family, ensuring they are informed about the evolving situation and involved in decision-making processes regarding care priorities and goals.

Section 3

As the healthcare team implements the discussed interventions, they closely monitor the patient's response to the adjusted oxygen therapy. The patient is transitioned to a high-flow nasal cannula (HFNC) with 60% FiO2, which helps increase his oxygen saturation to 92%, providing some relief from respiratory distress. Despite this improvement, his respiratory rate remains elevated at 28 breaths per minute, and he continues to exhibit moderate use of accessory muscles. The team initiates low-dose diuretics to address potential fluid overload contributing to the crackles in the right lung base, with a plan to titrate based on the patient's response and renal function, which remains stable with a creatinine level of 1.0 mg/dL.

In parallel, the team addresses the slight fever and potential infection risk due to possible tumor necrosis or systemic inflammation. Blood cultures are obtained, and a broad-spectrum antibiotic is started empirically while awaiting culture results. The elevation in liver function tests prompts a further review of the patient's medications and potential hepatotoxicity, with a temporary pause on any non-essential hepatically metabolized drugs. The patient's nutritional intake is carefully assessed, revealing a decrease in appetite and intake, likely due to increased metabolic demands and fatigue. Nutritional support is enhanced with calorie-dense supplements and, if needed, consideration for enteral nutrition to ensure adequate caloric intake and support immune function.

Through these targeted interventions, the healthcare team continues to focus on stabilizing the patient's condition while preparing for potential new complications. The multidisciplinary team, including palliative care, remains actively engaged in discussions with the patient and family, ensuring that care aligns with the patient's goals and wishes. As the team actively monitors for any new signs of deterioration, they remain vigilant for further oncologic complications and ready to adjust the treatment plan accordingly, keeping the patient's quality of life at the forefront of all decision-making processes.

Section 4

As the healthcare team continues to monitor the patient, there is a noticeable change in his status. Over the following 48 hours, the patient begins to exhibit signs of increased respiratory distress, despite the ongoing oxygen therapy via HFNC. His respiratory rate rises to 32 breaths per minute, and he becomes tachycardic with a heart rate of 112 beats per minute. There is an escalation in the use of accessory muscles, and the patient reports increased fatigue and difficulty in maintaining conversation due to shortness of breath. Auscultation reveals that the crackles in the right lung base have progressed, now extending to the mid-lung fields bilaterally, suggesting a possible worsening of pulmonary edema or new onset of pneumonia.

Concurrent with these respiratory changes, the patient's blood cultures return positive for Gram-negative rods, indicating a bacterial infection contributing to the current systemic inflammatory response. The patient develops leukocytosis with a white blood cell count of 15,000/mm³ and a further elevation in C-reactive protein, confirming the presence of an active infection. In response, the antibiotic regimen is adjusted based on culture sensitivities to ensure targeted antimicrobial therapy, and the team evaluates the need to escalate care, considering the possibility of transitioning to non-invasive ventilation or even intubation if the patient's respiratory status continues to decline.

The team recognizes the necessity of integrating these new complications into the patient's overall management plan. The involvement of infectious disease specialists is prioritized to refine antibiotic therapy, while pulmonary consultation is sought to reassess the efficacy of current respiratory support. Palliative care remains engaged, offering support to the patient and family, emphasizing comfort and quality of life in light of the evolving clinical picture. With the patient's nutritional status under strain due to increased metabolic demands and ongoing infection, the team re-evaluates the need for enteral nutrition to prevent further nutritional deficits. This coordinated approach ensures that all aspects of the patient's care are addressed comprehensively, with an eye toward balancing aggressive treatment with the patient's goals and preferences.

Section 5

As the team monitors the patient's response to the adjusted antibiotic regimen, initial signs indicate a slight improvement in systemic infection parameters; however, new complications arise that demand immediate attention. Over the next 24 hours, the patient's respiratory distress continues to escalate, leading to a critical reassessment of his respiratory support. Despite the high-flow nasal cannula, the patient’s oxygen saturation persistently hovers around 88-90%, and his gas exchange deteriorates as evident by an arterial blood gas analysis showing a pH of 7.32, PaCO2 of 52 mmHg, and PaO2 of 58 mmHg, indicating worsening respiratory acidosis.

Given these developments, the healthcare team deliberates the immediate transition to non-invasive positive pressure ventilation (NIPPV) to improve alveolar ventilation and oxygenation. The patient is placed on bi-level positive airway pressure (BiPAP), and efforts are made to optimize settings for maximum efficacy while monitoring for any signs of fatigue or intolerance to the intervention. The respiratory therapist adjusts the inspiratory positive airway pressure (IPAP) to 14 cm H2O and the expiratory positive airway pressure (EPAP) to 8 cm H2O, with close monitoring of tidal volume and patient comfort.

Despite these interventions, the patient begins to exhibit signs of hemodynamic instability. His blood pressure drops to 88/56 mmHg, and lactate levels rise to 3.8 mmol/L, suggesting the development of sepsis-induced hypotension. Fluid resuscitation is initiated with careful consideration to avoid exacerbating potential pulmonary edema, while vasopressor support with norepinephrine is considered to stabilize the patient's circulatory status. This evolving clinical picture necessitates ongoing multidisciplinary collaboration, with the team weighing the risks and benefits of further invasive procedures in light of the patient's overall prognosis and personal wishes, as outlined in previous palliative care discussions.